Research summary ·
Robotic pancreatic enucleation versus laparoscopic pancreatic enucleation: a meta-analysis.
Machine-written explainer in our own words, checked against the source record · 12 Nov 2026. How it's made
What was studied
This review compared robotic and laparoscopic surgery for pancreatic growths. The surgery spares pancreas tissue. It pooled cohort studies. They included 272 patients in total. 144 had laparoscopic surgery. 128 had robotic surgery. The team looked at safety and results around the operation.
What they found
Operation time did not differ significantly. Blood loss and pancreatic fistula did not differ either. Bleeding after surgery and major complications did not differ. Hospital stay after surgery was statistically shorter with robotic surgery.
What it means for patients
The authors say the evidence does not show a clear overall difference. This holds for efficacy and for safety. They say the shorter stay needs care in reading. It does not by itself prove a recovery edge.
Why it is not certain yet
The evidence base is small and observational. Other factors may still skew the results. The authors say this blocks a firm conclusion. They call for larger prospective multicentre studies. Tests for bias were left out. Few studies were available.
Source
Robotic pancreatic enucleation versus laparoscopic pancreatic enucleation: a meta-analysis.
PubMed · PMID 43007558We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Pancreatic cancer news